Cargando…

SAT-493 A Case of Profound Hypothyroidism Secondary to Immune Check Point Inhibitors

Background: The discovery of immune check-point inhibitors (ICI) revolutionized cancer treatment. CTLA-4, anti-PD-1 and anti-PD-L1 monoclonal antibodies have been approved in recent years. However, the advantageous clinical outcomes can also be associated with potentially severe immune related adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Tun, Yin Nwe, Rodriguez, Giovanna, Bahtiyar, Gul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209753/
http://dx.doi.org/10.1210/jendso/bvaa046.694

Ejemplares similares